Data tools to expand addiction services and reduce overdoses in Oregon
Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses
This project creates easy-to-use data tools for community leaders and health programs so Oregon can expand addiction services and prevent overdoses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Chestnut Health Systems, INC. NIH-funded |
| Lab location | 1 site (Bloomington, United States) |
| Project ID | NIH-11192940 on NIH RePORTER |
What this research studies
If you or your community are affected by opioid or methamphetamine use, this work brings together health, justice, and community groups to share practical data about service gaps and overdoses. Researchers will run collaborative "Discovery and Design" sessions with people who use services, providers, and policymakers to build dashboards and reports that answer real local questions. The team will pilot those tools during the rollout of Oregon's Measure 110 funding to see how they help guide decisions on where to place services. The aim is to make it easier for counties and service agencies to target treatment, harm reduction, and prevention where they are needed most.
Who could benefit from this research
Good fit: Ideal participants are people in Oregon affected by opioid or methamphetamine use, local service providers, and community leaders willing to share information and join co-design sessions.
Not a fit: People living outside Oregon or those not connected to the programs targeted by Measure 110 are unlikely to see direct benefits from this work.
Why it matters
Potential benefit: If successful, communities could use clearer data to direct funding and create more treatment and overdose-prevention services where they're most needed.
How similar studies have performed: Some local data-sharing initiatives have improved service planning, but combining statewide Measure 110 rollout with structured co-design sessions is relatively new.
Where this research is happening
Bloomington, United States
- Chestnut Health Systems, INC. — Bloomington, United States (Active)
Researchers
- Principal investigator: Cruden, Gracelyn — Chestnut Health Systems, INC.
- Study coordinator: Cruden, Gracelyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.